PASADENA, Calif., Feb. 6, 2025 /PRNewswire/ — Intuitive BioTechnologies LLC (IBT) is proud to announce they have added elemental analysis to their testing capabilities. IBT is now offering quantitative single or multi-element analysis as well as semi-quantitative screening. Using ICP-OES technology, IBT can quantify over 50 elements in a single measurement. Additionally, Agilent’s IntelliQuant software provides semi-quantitative data of abundant commonly detected elements found in each sample, enabling rapid method development. This technology helps reduce client’s cost and save valuable time and resources.
With its new addition, IBT can measure many elements down to 10 ppb and can even measure samples with up to 5% total dissolved solids. With the ability to test over 1000 samples a day, IBTs elemental analysis service comes with short turnaround time and competitive pricing. In adding to their current list of services, IBT can help meet your testing needs. “Whether you’re an early start-up performing discovery studies or an established company who needs to outsource lot release residuals testing, we’re here to help.” says Travis Jones, BD and Lab Manager, Intuitive Biotechnologies. “We want to help you get your product to the next step.”
About Intuitive BioTechnologies
IBT is a US service-based company that offers in-vitro biological and analytical tests. IBT’s goal is to offer affordable, rapid, and reliable testing services to the fast-growing life-science community. IBT offers its in-vitro biological and analytical tests for characterizing medical devices, therapeutics, and other regulated products. IBT works closely with their clients to ensure the appropriate tests are performed for each product. IBT also offers custom testing solutions to help companies transition between research, product development, and regulatory testing.
For more information contact IBT
Website: IntuitiveBioTech.com
Phone: (719) 413-7292
Email: Flowcytometry@intuitvebiotech.com
SOURCE Intuitive Biotechnologies
Clinical trial infrastructure fully operational in the U.S. with more than 15 leading cardiovascular centers…
CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…
MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…